Chromogranin A, a Marker of the Therapeutic Success of Resection of Neuroendocrine Liver Metastases: Preliminary Report

By Søndenaa Karl  

World Journal of Surgery, Vol. 28, Iss. 9, 2004-09 ,pp. : 890-895

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma

By Froschermaier S.E.   Pilarsky C.P.   Wirth M.P.  

Urology, Vol. 47, Iss. 4, 1996-04 ,pp. : 525-528

Elsevier

Access to resources Recommend Favorite

Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate

By Krupski T.   Petroni G.R.   Frierson H.F.   Theodorescu J.o.U.U.o.V.H.S.C.C.V.U.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 743-749

Elsevier

Access to resources Recommend Favorite

A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate

By Giordano Salvatore  

International Urology and Nephrology, Vol. 42, Iss. 3, 2010-09 ,pp. : 683-687

Springer Publishing Company

Access to resources Recommend Favorite

Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer - a marker of androgen-independent (AI) growth in prostatic carcinoma (PC).(abstract)

By Veltri R.W.   Miller M.C.   Zhao G.   Ng A.   Marley G.M.   Wright G.L.   Vessella R.L.   Ralph D.  

Urology, Vol. 53, Iss. 1, 1999-01 ,pp. : 139-147

Elsevier

Access to resources Recommend Favorite